Leaflet METAMIZOL SODIC Pml 500mg / ml solution for injection


Indicated for: pain and inflammation

Route of administration: injectable

Substance: metamizole sodium (nonsteroidal anti-inflammatory drug)

ATC: N02BB02 (Nervous system | Other analgesics and antipyretics | Pyrazolones)

Precautions:
Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Nephrotoxicity
Nephrotoxicity

This medicine may affect the kidneys.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Bleeding risk
Bleeding risk

This medicine may increase the risk of bleeding.

Ulcer / gastrointestinal bleeding
Ulcer / gastrointestinal bleeding

This medicine may increase the risk of ulcer or gastrointestinal bleeding.

Metamizole sodium, also known as Dipyrone, is a medication used to relieve moderate to severe pain and to reduce fever that does not respond to other treatments. It is an analgesic and antipyretic from the pyrazolone class, with antispasmodic properties, making it useful for treating renal or biliary colic.

Metamizole works by inhibiting the synthesis of prostaglandins, substances involved in inflammation and pain perception. It is available in tablet form, injectable solutions, or suppositories and is used for both short-term treatments and acute situations.

Side effects may include allergic reactions, low blood pressure (especially with injectable forms), and, in rare cases, agranulocytosis (a severe decrease in white blood cells). For this reason, long-term use is discouraged, and it should be taken only as prescribed by a doctor. It is contraindicated during pregnancy, breastfeeding, and in patients with hematological disorders.

General data about METAMIZOL SODIC Pml 500mg / ml

  • Substance: metamizole sodium
  • Date of last drug list: 01-06-2020
  • Commercial code: W66670001
  • Concentration: 500mg / ml
  • Pharmaceutical form: solution for injection
  • Quantity: 10
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: SOPHARMA AD - BULGARIA
  • Holder: PHARMA MARKETING LINE SRL - ROMANIA
  • Number: 12649/2019/01
  • Shelf life: 5 years

Pharmaceutical forms available for metamizole sodium

Concentrations available for metamizole sodium

  • 1000mg
  • 300mg
  • 500mg
  • 500mg/ml

Other substances similar to metamizole sodium

Combinations with other substances